Carigent Therapeutics

5 Science Park, Suite 13
New Haven, CT 06511

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $455K
First Award Date 09/28/07
Most Recent Award Date 09/15/08

Key Personnel

Last Name Name Awards Contact
Fong Peter Marc Fong 2 Message
Cartiera Malgorzata Cartiera 1

3 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-09
Budget: 09/15/08 - 08/31/09

DESCRIPTION (provided by applicant): The long-term clinical objective of this proposal "Multimodal Diagnostic and Therapeutic Nanoparticles for Non-Hodgkin's Lymphoma" is the development of a novel therapeutic and diagnostic drug delivery technology for specific use in the treatment of non-Hodgkin's lymphoma. The combination of non-invasive imag...

Phase 1 SBIR

Agency: National Science Foundation
Topic: 2008
Budget: 01/01/08 - 12/31/08

PARS Summary This Small Business Innovation Research (SBIR) Phase I research project aims to develop paclitaxel-loaded nano particles with avidin modified surfaces for the targeting of the drug to cells that express an appropriate receptor for which the particle also carries the ligand. Tumor-specific targeting of drugs is one of the most sough...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-09
Budget: 09/28/07 - 08/31/08

DESCRIPTION (provided by applicant): The long-term objectives of this proposal "Long-Circulating Targeted Nanoparticles for Non-Hodgkin's Lymphoma Treatment" are to (1) develop a novel, surface-modified PLGA nanoparticle system for the targeted delivery of therapeutic compounds and (2) use this technology to improve doxorubicin safety and effica...